Real-world outcomes of a placenta-based tissue product versus standard of care for lower extremity diabetic ulcers: a Medicare cohort study

Medicare patients treated with DLAM experienced significantly lower rates of major amputations and reduced healthcare use compared with those treated with debridement alone. Promising results from this study may provide another advanced wound care option to add to the treatment armamentarium.